Opportunity and Threat Assessment2019-11-12T12:05:13+00:00

Opportunity and Threat Assessment

As markets become ever more complex and competition increases, the ability to properly assess opportunities and threats by truly understanding and exploiting the strategic intent of competitors is becoming more important than ever.

The service provided by Deallus strengthens your competitive strategy by revealing the hidden opportunities that exist behind market threats.

Deallus Market landscape assessment

Market landscape assessment

Therapy area landscaping to understand market dynamics and identify emerging technology and products

Deallus Treatment drivers exploration

Treatment drivers exploration

Mapping treatment decision drivers and how they change over time

Deallus Decision framework development

Decision framework development

Creating decision frameworks to cultivate tangible action plans for opportunities and threats

Deallus Product profile analysis

Product profile analysis

Developing a product profile founded upon a deep understanding of product value, positioning and patient segmentation

Competitor evaluation

Evaluating competitors based on enhanced awareness of commercial capabilities, behaviour, positioning, and R&D progressions

Deallus Market asset attractiveness

Market/asset attractiveness

Considering attractiveness for indication prioritisation, entry, and expansion

Find out more

Opportunity and threat assessment related insight

All Deallus Insight

Competitive Simulation Strategy

Categories: Case Study|Tags: , , , |

Our client was facing a major pharma player in a highly lucrative and rare disease space. They wanted to ensure that they had a chance to analyze their competition’s launch plan and plans for targeting their own product, but they did not have the time to conduct a cross-functional, traditional workshop. They came to us to discuss their goals and assess the most strategic way forward. This case study explores this launch scenario in which we put a unique spin on the traditional competitive simulation approach for our client.

Asia Market Entry

Categories: White Paper|Tags: , , |

A continent of extremes, with great potential for growth. Geographically large, the assortment of cultures, people, disease profiles, and healthcare systems added to the juxtaposition of extreme wealth and extreme poverty, emphasises the many challenges faced by the pharmaceutical companies when thinking of entering Asia. Commercial success will depend on understanding the market dynamics by consolidating positioning within the market place with the requirements of each market.

Asian Pricing and Reimbursement

Categories: White Paper|Tags: , , , |

Growing major trends are emerging across Asian healthcare markets. Rising incomes, increased government healthcare expenditure, higher life expectancies and a surge of chronic illnesses are boosting the demand for pharmaceutical products and services in the region. We take a look at the emerging trends across Asian healthcare systems and the implications for the industry.